Does alpha-galactosidase reduce gas from beans and vegetables?
Possibly — trial evidence is genuinely mixed. Some controlled trials show a benefit for gas-related symptoms, but a more recent trial in IBS patients found no benefit over placebo.
Quick answer
Best suited for
- Occasional gas from specific foods like beans, lentils, and cruciferous vegetables containing raffinose-family oligosaccharides.
- People looking for a low-risk product to try with a gas-producing meal.
It is unlikely to help with
- A treatment for IBS itself — a recent randomized crossover trial in IBS patients found it was not superior to placebo.
- A guaranteed fix — some controlled trials support a benefit, but the evidence is inconsistent, not uniformly positive.
What to compare on the label
- Activity unit — Look for GalU (Galactosidase Unit) at the labeled serving size.
- Trigger foods — Most useful for specific known trigger foods (beans, lentils, cruciferous vegetables) rather than general bloating.
Where to find it
Beano (Prestige Consumer Healthcare) — Beano Digestive Enzyme Tablets, Original Strength
Beano is the most recognized alpha-galactosidase brand and the one this guide's own title and meta description already reference by name. We link to it as the standard, most-studied example of the enzyme class — not because we rate alpha-galactosidase's evidence as strong. See the guide's own evidence section: results across trials are genuinely mixed, including at least one negative trial in IBS patients. This reflects the manufacturer's own published label (beanogas.com), not Enzyax's independent lab testing.
View on Amazon →As an Amazon Associate, Enzyax earns from qualifying purchases.
What the trials show
A randomized, double-blind, placebo-controlled trial in children found alpha-galactosidase significantly reduced overall distress and the number of days with moderate-to-severe bloating compared to placebo.
A more recent randomized crossover trial in adults with irritable bowel syndrome (IBS) found alpha-galactosidase was not superior to placebo for reducing gas or other symptoms after a high-oligosaccharide meal.
Several of the earlier supportive trials were small, and much of the foundational research dates back to the 1990s — a real limitation when weighing how confident to be in the effect.
Put plainly: some people report real relief, some controlled trials support that, and at least one well-designed recent trial in IBS patients specifically did not find a benefit. This is a case where "it worked for me" and "the trial data is inconsistent" can both be true at once.
- If gas or bloating is persistent, severe, or part of a broader pattern that could be IBS or another condition, that's a question for a clinician, not just an enzyme trial.
Sources: Ohtsuka et al., "Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial" — PubMed 24063420; Böhn et al., "Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients" — PubMed 33619835. Last reviewed: July 28, 2026.